Del Galdo, F. et al. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-226430 (2024).

Article  PubMed  Google Scholar 

Coleiro, B. et al. Treatment of Raynaud’s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology 40, 1038–1043 (2001).

Article  CAS  PubMed  Google Scholar 

Khan, M. S. et al. Is anticoagulation beneficial in pulmonary arterial hypertension? A systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes 11, e004757 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Ebata, S. et al. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 3, e489–e497 (2021).

Article  CAS  PubMed  Google Scholar 

Ebata, S. et al. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 4, e546–e555 (2022).

Article  CAS  PubMed  Google Scholar 

Ebata, S. et al. Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial. Rheumatology 61, 4364–4373 (2022).

Article  CAS  PubMed  Google Scholar 

Sircar, G. et al. Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial. Rheumatology 57, 2106–2113 (2018).

Article  CAS  PubMed  Google Scholar 

Denton, C. P. et al. The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology 63, 2956–2975 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Highland, K. B. et al. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet Respir. Med. 9, 96–106 (2021).

Article  CAS  PubMed  Google Scholar 

Johnson, S. R. et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Rheumatol. 76, 1051–1069 (2024).

Article  Google Scholar